You are here: Industry Insights > cancer

News List

More Antibiotics, Higher Odds for Colon Cancer? drugs
August 22, 2019
Taking certain antibiotics -- especially multiple times or for long courses -- may put you at risk for colon cancer, a large new study suggests.
Selinexor Offers Hope Against a Tough-to-Treat Blood Cancer drugs
August 22, 2019
Patients with a form of blood cancer known as multiple myeloma who haven't responded to other therapies might have a new weapon against the disease, researchers say.
Oral Antibiotic Use Linked to Risk for Colorectal Cancer drugs
August 22, 2019
Oral antibiotic use is associated with an increased risk for colon cancer and a reduced risk for rectal cancer, according to a study published online in Gut.
Odds of Developing C. Diff Increased in Older Cancer Patients drugs
August 22, 2019
Older adults with cancer have increased odds of developing Clostridiodes difficile infection (CDI), according to a study published in the September issue of Emerging Infectious Diseases...
Lipophilic Statins May Cut Liver Cancer in Chronic Viral Hepatitis drugs
August 21, 2019
Lipophilic statin use is associated with significantly reduced hepatocellular carcinoma (HCC) incidence and mortality in adults with chronic viral hepatitis...
Minority, Low-Income Individuals Less Likely to Receive Oral Cancer Screening drugs
August 21, 2019
Despite a recent dental visit, more individuals of a minority race/ethnicity and low socioeconomic status report not receiving an oral cancer screening exam...
U.S. Task Force Updates Breast Cancer Gene Testing Recommendations drugs
August 21, 2019
Mutations in two genes -- BRCA1 and BRCA2 -- are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them.
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer drugs
August 21, 2019
Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the risk for death...
Study finds lack of racial diversity in cancer drug clinical trials worldpharmanews
August 20, 2019
New research published in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study - conducted by researchers from UBC, the University of Texas MD Anderson Cancer Center...
FDA grants Rozlytrek cancer treatment approval drugs
August 19, 2019
The cancer therapeutic, Rozlytrek, has gained FDA approval as well as Priority Review, Breakthrough Therapy and Orphan Drug Designations.